financetom
Business
financetom
/
Business
/
Troubled casino operator Star Entertainment falls on further earnings deterioration
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Troubled casino operator Star Entertainment falls on further earnings deterioration
Nov 3, 2024 2:35 PM

(Reuters) - Embattled casino operator Star Entertainment slumped on Wednesday, after swinging to a first-quarter loss and reporting a drop in revenue, adding to the rising uncertainty about its future revamp and earnings turnaround.

Shares of the Australian gaming group fell as much as 15.1% to A$0.243, on track for its weakest trading session since Sept. 27. The stock was the top loser in the benchmark S&P/ASX 200 index.

Star reported an 18% drop in revenue to A$351 million ($230.19 million) for the three months ended September, with a loss before interest, tax, depreciation and amortisation of A$18 million.

Star cited a challenging operating environment and restrictions such as a mandatory carded play and cash limits for the decline in earnings.

"The impact of a more challenging consumer environment, loss of market share and the impact of changed business practices continue to negatively impact top-line performance," Star said on Tuesday.

"Carded gaming rollout poses a significant risk to the underlying business in Queensland even if one looks through significant balance sheet and cashflow issues," Jefferies said.

The debt-laden gaming firm has been in the eye of a perfect storm that has hit the Australian casino operators for years, with Star and Blackstone-owned larger rival Crown Resorts being engulfed with multiple regulatory inquiries amid muted tourist visits and long closures.

Over the last few years, Star's board and management team have been hit with two Bell inquiries, lost its CEO and chairman and has almost gone broke.

The company said it had available cash of A$149 million at the end of September - which included proceeds of A$60.5 million from the sale of the Treasury casino building in Brisbane.

"1Q25 trading update reflects a further deterioration in conditions," analysts at Jefferies said in a note, adding that they currently see limited catalysts for an earnings turnaround at the casino firm.

($1 = 1.5249 Australian dollars)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Kroger, Albertsons amend asset sale agreement with C&S Wholesale
Kroger, Albertsons amend asset sale agreement with C&S Wholesale
Apr 22, 2024
(Reuters) -Kroger ( KR ) and Albertsons Cos ( ACI ) said on Monday that they have amended their definitive agreement with C&S Wholesale Grocers for the sale of assets in connection with their proposed merger. The companies have updated their divestiture package to increase the total store count by 166 to include 579 stores that will be sold to...
IDEAYA Biosciences Selects Move-Forward Expansion Dose for Mid-Stage Trial of IDE397 Monotherapy
IDEAYA Biosciences Selects Move-Forward Expansion Dose for Mid-Stage Trial of IDE397 Monotherapy
Apr 22, 2024
08:45 AM EDT, 04/22/2024 (MT Newswires) -- IDEAYA Biosciences ( IDYA ) said Monday that it has selected a move-forward expansion dose for a mid-stage trial evaluating its IDE397 monotherapy in MTAP-deletion squamous non-small cell lung cancer, or NSCLC. Squamous NSCLC has been identified as the most sensitive tumor type of IDE397 monotherapy, the company said. There are more than...
Lexeo Therapeutics Signs License Deal With Cornell for Potential Friedreich Ataxia Cardiomyopathy Drug
Lexeo Therapeutics Signs License Deal With Cornell for Potential Friedreich Ataxia Cardiomyopathy Drug
Apr 22, 2024
08:47 AM EDT, 04/22/2024 (MT Newswires) -- Lexeo Therapeutics ( LXEO ) said Monday that it has signed an in-license agreement with Cornell University to expedite the development of investigational gene therapy candidate LX2006 to treat Friedreich ataxia cardiomyopathy. Under the deal, Lexeo said it has acquired certain rights, including rights to current and future data generated in an ongoing...
Red Pine Exploration Says Michael Michaud Joining as its President & CEO and as a Member of its Board; He Has Experience With Wesdome and Iamgold
Red Pine Exploration Says Michael Michaud Joining as its President & CEO and as a Member of its Board; He Has Experience With Wesdome and Iamgold
Apr 22, 2024
08:42 AM EDT, 04/22/2024 (MT Newswires) -- Red Pine Exploration Inc. ( RDEXF ) on Monday announced that Michael Michaud will be joining Red Pine as its President & Chief Executive Officer and as a member of its board of directors. According to a statement, Michaud is a Professional Geologist with over 30 years of experience in domestic and international...
Copyright 2023-2026 - www.financetom.com All Rights Reserved